Contact Sign In
Request Demo
Featured Content
HealthVerity MarketplaceTM

The nation’s largest healthcare and consumer data ecosystem

taXonomy Pathways

Unique features per therapeutic area with claims, labs and EHR including notes

HealthVerity eXOs

AI-native real-world evidence generation

Identity Manager (HVID)

Standalone de-identification as a service

Data Ecosystem
HealthVerity MarketplaceTM
HealthVerity TaxonomySM
HealthVerity Notes
Precision Event Alerts
HealthVerity Mastersets
Media Measurement
Syndicated Audiences
Insurance Underwriting
Technology Products
Identity Manager (HVID)
HealthVerity for Clinical Trial Linkage
HealthVerity for Commercial
Smart Contracts
HealthVerity for Registries
Life Sciences

Technology solutions from development through commercialization

Channel Partners

HealthVerity enables partners to unlock unprecedented value and insights for clients

Government

Comprehensive and compliant solutions to manage the nation’s care

Data Ecosystem Partners

Join the nation’s largest data partner ecosystem

Insurance

Insurance-grade solutions that excel in managing risk and rebates

HealthVerity Blog

Insights and updates from industry experts

Publications

Peer-reviewed research and discoveries

News & Events

Stay informed about our latest announcements and happenings

The IPGE Approach

Fundamentals that power everything that we do and every solution we offer

Resource Library

Explore guides, webinars, and tools to enhance your understanding

Zombie Data Explained

Learn how data quality drives better research outcomes

GLP-1 persistence: What semaglutide data reveals about patient behavior

As the new year begins, many patients refocus on weight management and long-term health goals. At the same time, GLP-1 drugs have reshaped the obesity treatment landscape.1,2 With semaglutide and other GLP-1 medications in high demand for weight loss...

Read more

Contact us